6H-Indolo[3,4-gh][1,4]benzoxazine,5-bromo-4,6a,7,8,9,10a-hexahydro-7-propyl-, monohydrochloride, (6aR,10aR)-rel-(9CI) (80952-19-8)

Identification
Name:	6H-Indolo[3,4-gh][1,4]benzoxazine,5-bromo-4,6a,7,8,9,10a-hexahydro-7-propyl-, monohydrochloride, (6aR,10aR)-rel-(9CI)
CAS:	80952-19-8
Molecular Formula:	C16H19 Br N2 O . Cl H
Molecular Weight:	371.6998
InChI:	InChI=1/C16H19BrN2O.ClH/c1-2-6-19-7-8-20-15-10-4-3-5-12-14(10)11(9-13(15)19)16(17)18-12;/h3-5,13,15,18H,2,6-9H2,1H3;1H/t13-,15-;/m1./s1
Molecular Structure:
Properties
Flash Point:	246.7°C
Boiling Point:	484.4°C at 760 mmHg
Flash Point:	246.7°C
Safety Data

Other Product

6H-Indolo[3,4-gh][1,4]benzoxazine,4,6a,7,8,9,10a-hexahydro-7-propyl-, monohydrochloride, (6aR,10aR)- (9CI)
(6aR,10aR)-7-methyl-9-[(methylsulfanyl)methyl]-4,6a,7,8,9,10a-hexahydro-6H-indolo[3,4-gh][1,4]benzoxazine
(5aS,6aS,10aS)-7-propyl-4,5,5a,6a,7,8,9,10a-octahydro-6H-indolo[3,4-gh][1,4]benzoxazine
1H,3H-Furo[3',4':4,5]cyclohept[1,2-d]isobenzofuran-3,10(8H)-dione,12-(acetyloxy)-8-(3-furanyl)-5,6,6a,10a,11,12-hexahydro-7-methyl-,(6aR,8R,10aR,12R,12aR)-rel-
6H-Indolo[4,3-fg][2,1]benzoxazine,4,6a,7,9,10,10a-hexahydro-, (6aR,10aR)- (9CI)
(6aR,10aR)-6,6,9-trimethyl-10a-(pentan-3-yl)-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-yl 4-(morpholin-4-yl)butanoate hydrobromide (1:1)
(6aS,8R,10aR)-10a-[(4-Chlorophenyl)sulfonyl]-1,4-difluoro-6a,7,8, 9,10,10a-hexahydro-6H-benzo[c]chromen-8-ol
6H-Dibenzo[b,d]pyran-4-carboxylicacid, 6a,7,10,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-3-propyl-, (6aR,10aR)-
7H-Indolo(3,4-gh)(1,4)benzoxazine, 4,6,6a,8,9,10a-hexahydro-5-bromo-7-methyl-, oxalate, (+-)-(6-ars,10-ars)-
(6aR,8S,10aS)-10a-[(4-Chlorophenyl)sulfonyl]-1,4-difluoro-6a,7,8, 9,10,10a-hexahydro-6H-benzo[c]chromen-8-ol
7-propyl-4,6a,7,8,9,10a-hexahydro-6H-indolo[3,4-gh][1,4]benzoxazin-7-ium chloride
6H-Dibenzo[b,d]pyran-9-carboxylicacid, 6a,7,8,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-(pentyl-5,5,5-d3)-,(6aR,10aR)-rel- (9CI)
6H-Dibenzo[b,d]pyran-9-carboxylicacid, 6a,7,8,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-, (6aR,10aR)-rel-
6H-Dibenzo[b,d]pyran-9-methanol,3-(1,1-dimethylheptyl)-6a,7,8,9,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-,(6aR,9R,10aR)-
4H-Indolo[4,3-fg][3,1]benzoxazine, 6,6a,7,8,10,10a-hexahydro-7,8-dimethyl-10-(1-methylethenyl)-,(6aR,8R,10R,10aR)- (9CI)
4-Morpholinebutanoicacid,(6aR,10aR)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ylester
6H-Dibenzo[b,d]pyran-4-carboxylicacid, 6a,7,10,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-
6H-Dibenzo[b,d]pyran-4-carboxylicacid, 6a,7,8,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-
5H,7H-5a,6a-Ethanopyrrolo[1'',2'':1',7']azepino[4',5':2,3]cycloprop[1,2-b]indole-5-carboxylicacid, 5a,6,8,9,11,12-hexahydro-2-methoxy-, methyl ester,(5aR,5bS,6aR,12aR)-rel-(-)- (9CI)
4-Morpholinebutanoic acid (6aR,10aR)-3-(5-cyano-1,1-dimethylpentyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]-1-benzopyran-1-yl ester hydrochloride